Blog
RSS FeedPosted by Michael Wonder on 03 Sep 2022
Swissmedic authorises Novavax Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17 and as a booster in adults aged 18 and older
2 September 2022 - Novavax today announced that Swissmedic has expanded its temporary authorisation of Nuvaxovid COVID-19 vaccine in Switzerland for ...
Posted by Michael Wonder on 01 Sep 2022
EMA CHMP adopts positive opinion recommending authorisation for the use of Moderna's Omicron targeting bivalent booster in the European Union
1 September 2022 - Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 sub-variants when ...
Posted by Michael Wonder on 01 Sep 2022
Health Canada authorises first bivalent COVID-19 booster for adults 18 years and older
1 September 2022 - Today, Health Canada authorised an adapted version of the Moderna Spikevax COVID-19 vaccine. ...
Posted by Michael Wonder on 01 Sep 2022
First adapted COVID-19 booster vaccines recommended for approval in the EU
1 September 2022 - The EMA’s CHMP has recommended authorising two vaccines adapted to provide broader protection against COVID-19. ...
Posted by Michael Wonder on 31 Aug 2022
FDA authorises Moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose
31 August 2022 - Today, the US FDA amended the emergency use authorisations of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech ...
Posted by Michael Wonder on 30 Aug 2022
TGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults
30 August 2022 - On 29 August 2022, the TGA provisionally approved Moderna's bivalent COVID-19 vaccine, elasomeran with imelasomeran (Spikevax Bivalent ...
Posted by Michael Wonder on 30 Aug 2022
COVID-19 vaccines undergoing evaluation (30 August 2022)
30 August 2022 - The TGA has updated its list of the applications it has received for COVID-19 vaccines using the ...
Posted by Michael Wonder on 30 Aug 2022
Swissmedic authorises Moderna's Omicron targeting bivalent booster candidate MRNA-1273.214
29 August 2022 - Switzerland becomes among the first countries in the world to approve the use of a next-generation ...
Posted by Michael Wonder on 29 Aug 2022
FDA expected to authorise Moderna, Pfizer-BioNTech Omicron boosters
29 August 2022 - The move would set the stage for the Biden administration to begin offering the reformulated vaccine shortly ...
Posted by Michael Wonder on 27 Aug 2022
Pfizer and BioNTech complete submission to EMA for Omicron BA.4/BA.5 adapted bivalent vaccine
26 August 2022 - Submission follows application for Omicron BA.1 adapted bivalent vaccine submitted in July. ...
Posted by Michael Wonder on 26 Aug 2022
ATAGI update following weekly COVID-19 meeting (24 August 2022)
26 August 2022 - On Wednesday 24 August 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. ...
Posted by Michael Wonder on 25 Aug 2022
Novavax vaccine for adolescents aged 12-17 years
25 August 2022 - The Australian Technical Advisory Group on Immunisation has evaluated data on immunogenicity, efficacy, safety, and international ...
Posted by Michael Wonder on 25 Aug 2022
FDA plans to authorise bivalent boosters by Labor Day, sources say
24 August 2022 - The FDA plans to authorise updated versions of Pfizer-BioNTech’s and Moderna’s Covid boosters around Labor Day, ...
Posted by Michael Wonder on 25 Aug 2022
COVID-19 vaccine safety report (25 August 2022)
25 August 2022 - To 21 August 2022, the TGA has received 674 reports which have been assessed as likely to ...
Posted by Michael Wonder on 23 Aug 2022
Moderna completes application to US FDA for emergency use authorisation of omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222
23 August 2022 - Clinical data available for Moderna's bivalent COVID-19 booster vaccines have met all primary endpoints and support ...